Return to study ST002523 main page
MB Sample ID: SA254502
| Local Sample ID: | MT242 |
| Subject ID: | SU002623 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Age Or Age Range: | 68 (63, 73) |
| Weight Or Weight Range: | 77 (62, 87) |
| Height Or Height Range: | 170 (160, 176) |
| Gender: | Male and female |
| Human Ethnicity: | White |
| Human Medications: | anti-PD-1 immune checkpoint inhibitors (nivolumab or pembrolizumab) |
| Human Inclusion Criteria: | consecutive advanced cancer patients |
Select appropriate tab below to view additional metadata details:
Combined analysis:
| Analysis ID | AN004157 |
|---|---|
| Analysis type | MS |
| Chromatography type | Reversed phase |
| Chromatography system | Thermo Vanquish |
| Column | Waters ACQUITY UPLC HSS T3 (150 x 2.1mm,1.8um) |
| MS Type | ESI |
| MS instrument type | QTRAP |
| MS instrument name | Thermo Orbitrap Exploris 240 |
| Ion Mode | UNSPECIFIED |
| Units | Peak area |
MS:
| MS ID: | MS003904 |
| Analysis ID: | AN004157 |
| Instrument Name: | Thermo Orbitrap Exploris 240 |
| Instrument Type: | QTRAP |
| MS Type: | ESI |
| MS Comments: | The ionization was achieved with an electrospray ionization interface operated in positive and negative ionization mode under polarity switching. Data were processed using Compound Discoverer 3.3 (Thermo Fisher Scientific) and Skyline 21.2. |
| Ion Mode: | UNSPECIFIED |
